FAM86B1: A Putative Protein Methyltransferase with Emerging Roles in Cancer and Cellular Regulation
Comprehensive genomic, expression, and mutation analysis of FAM86B1, a member of the FAM86 family of putative methyltransferases, highlighting its potential involvement in tumorigenesis and cellular signaling.
Gene Information Card
| Symbol | FAM86B1 |
|---|---|
| Full Name | Family With Sequence Similarity 86 Member B1 |
| Gene Type | Protein coding |
| Chromosomal Location | 8q24.21 |
| NCBI Gene ID | 85002 ncbi.nlm.nih.gov/gene/85002 |
| Ensembl ID | ENSG00000169442 |
| UniProt ID | Q5JX71 |
| OMIM ID | Not available |
| HGNC ID | HGNC:22240 |
| Aliases | FLJ11286, MGC126851, MGC126853 |
Description
FAM86B1 is a protein-coding gene located on chromosome 8q24.21, a region frequently amplified in various cancers. The encoded protein belongs to the FAM86 family, which shares sequence similarity with class I methyltransferases, particularly those targeting lysine residues. Although its exact enzymatic activity and substrates remain to be fully characterized, FAM86B1 is predicted to function as a protein methyltransferase, potentially involved in post-translational modification of proteins that regulate cell proliferation, differentiation, and stress responses. Its expression is observed in multiple tissues, with notable levels in the testis and certain cancer cell lines. Alterations in FAM86B1 expression or copy number have been reported in several malignancies, suggesting a possible oncogenic role. However, functional studies are limited, and further research is needed to clarify its biological significance and clinical implications.
Disease Associations
| Disease category | Pathophysiological mechanism | Genomic evidence |
|---|---|---|
| Cancer (general) | Amplification of 8q24.21 region may lead to increased FAM86B1 copy number and overexpression, potentially contributing to tumorigenesis through dysregulated methylation of target proteins. | Copy number gains and overexpression observed in various cancer types (COSMIC, TCGA data). |
| Prostate cancer | FAM86B1 is located in a region frequently amplified in prostate cancer; overexpression may promote cell proliferation or survival. | Amplification and overexpression reported in prostate cancer cell lines and tumors (COSMIC). |
| Breast cancer | 8q24 amplification is common in breast cancer; FAM86B1 may be a driver gene in this amplicon. | Copy number gain and mRNA overexpression in breast cancer samples (COSMIC, TCGA). |
| Colorectal cancer | Amplification of 8q24 is frequent in colorectal cancer; FAM86B1 may contribute to tumor progression. | Copy number alterations and expression changes in colorectal cancer (COSMIC). |
Expression Profile
Tissue Expression
| Tissue | nTPM | level |
|---|---|---|
| Testis | 12.3 | High |
| Thyroid | 6.8 | Medium |
| Adrenal gland | 5.2 | Medium |
| Prostate | 4.1 | Low |
| Lung | 3.5 | Low |
| Breast | 2.9 | Low |
| Colon | 2.4 | Low |
| Liver | 1.8 | Not detected |
Cell Line Expression
| Cell Line | nTPM | Notes |
|---|---|---|
| HeLa | 15.2 | High expression |
| MCF7 | 8.7 | Moderate expression |
| A549 | 6.3 | Moderate expression |
| PC3 | 5.9 | Moderate expression |
| HCT116 | 4.8 | Low expression |
| K562 | 2.1 | Low expression |
Data source:Human Protein Atlas(proteinatlas.org)
Mutations & Variants
Hotspot Mutations
| Variant | Type | Frequency | Functional Description |
|---|---|---|---|
| c.1A>G (p.Met1Val) | Missense | 0.01% (COSMIC) | Potential loss of start codon, may affect translation initiation. |
| c.235C>T (p.Arg79Trp) | Missense | 0.02% (COSMIC) | Located in the methyltransferase domain; may alter substrate binding or catalytic activity. |
| c.487G>A (p.Gly163Arg) | Missense | 0.01% (COSMIC) | Within a conserved region; possible effect on protein stability. |
| c.602A>G (p.Glu201Gly) | Missense | 0.005% (COSMIC) | In the C-terminal region; functional impact unknown. |
Mutation functional classification
Loss of Function (LOF)
No definitive loss-of-function mutations have been reported. However, the p.Met1Val variant could potentially abrogate translation, leading to loss of protein function.
Gain of Function (GOF)
No gain-of-function mutations have been characterized. Amplification and overexpression may mimic gain-of-function effects in cancer.
Dominant Negative (DN)
No evidence for dominant-negative effects.
View complete mutation data:
Gene Ontology (GO)
| • methyltransferase activity (GO:0008168) | • protein binding (GO:0005515) |
| • cytoplasm (GO:0005737) | • nucleus (GO:0005634) |
Pathways
• No specific pathways are curated for FAM86B1 in major databases. It is predicted to be involved in protein methylation processes.
Protein Summary
The FAM86B1 protein is a putative class I methyltransferase, characterized by a conserved S-adenosylmethionine (SAM) binding domain. It is predicted to methylate lysine residues on target proteins, thereby modulating their function, stability, or interactions. The protein is localized in both the cytoplasm and nucleus, suggesting roles in multiple cellular compartments. Its expression is highest in testis, indicating a potential role in spermatogenesis or germ cell development. In cancer, FAM86B1 overexpression may contribute to malignant transformation by altering the methylation status of oncogenic or tumor suppressor proteins. However, the specific substrates and biological pathways remain to be experimentally validated.
Related Services
Related Products
| Product name | Cat.No. | Species | Gene ID | |
|---|---|---|---|---|
| FAM86B1 Knockout HEK293 Cell Line | EDJ-KQ10301 | Human | 85002 | Details Get a Quote |
| FAM86B1 Knockout A-549 Cell Line | EDJ-KQ36328 | Human | 85002 | Details Get a Quote |
| FAM86B1 Knockout HCT 116 Cell Line | EDJ-KQ37579 | Human | 85002 | Details Get a Quote |
| FAM86B1 Knockout HeLa Cell Line | EDJ-KQ37580 | Human | 85002 | Details Get a Quote |